» Articles » PMID: 14525595

Development of a Novel Transgenic Mouse for the Study of Interactions Between CD4 and CD8 T Cells During Graft Rejection

Overview
Journal Am J Transplant
Publisher Elsevier
Specialty General Surgery
Date 2003 Oct 4
PMID 14525595
Citations 126
Authors
Affiliations
Soon will be listed here.
Abstract

The goal of this study was the development of a system in which the cooperative interactions between CD4 and CD8 T cells specific for defined peptides from a single minor histocompatibility antigen could be studied. A transgenic mouse strain that expresses chicken ovalbumin (Act-mOVA) on the surface of all cells in the body was produced as a source of tissues containing such an antigen. Skin grafts from Act-mOVA donors were rapidly and completely rejected by wild-type recipients, but only when both CD4 and CD8 T cells were present. CD4 T cells by themselves caused an incomplete form of rejection characterized by rapid but partial contraction of Act-mOVA grafts. CD8 T cells alone caused complete rejection of Act-mOVA skin grafts but only after a long delay. Adoptively transferred ovalbumin-specific TCR-transgenic CD4 and CD8 T cells were stimulated by Act-mOVA graft antigens and CD8 T-cell accumulation in the grafts was enhanced by specific CD4 T cells. These findings, together with the fact that the ligand for ovalbumin peptide-specific CD8 T cells can be detected in Act-mOVA tissues with an MHC-restricted antibody, make this an ideal system for the study of cooperation between CD4 and CD8 T cells.

Citing Articles

Immune suppression sustained allograft acceptance requires PD1 inhibition of CD8+ T cells.

Miller-Handley H, Harper G, Pham G, Turner L, Shao T, Russi A J Immunol. 2025; 214(1):192-198.

PMID: 40073258 PMC: 11904129. DOI: 10.1093/jimmun/vkae007.


The covalent modification of STAT1 cysteines by sulforaphane promotes antitumor immunity via blocking IFN-γ-induced PD-L1 expression.

Shi Q, Liu Y, Yang W, Li Y, Wang C, Gao K Redox Biol. 2025; 81:103543.

PMID: 39961271 PMC: 11875811. DOI: 10.1016/j.redox.2025.103543.


Differential induction of donor-reactive Foxp3 regulatory T cell via blockade of CD154 vs CD40.

Liu D, Yao H, Ferrer I, Ford M Am J Transplant. 2024; 24(8):1369-1381.

PMID: 38552961 PMC: 11305915. DOI: 10.1016/j.ajt.2024.03.033.


A humanized IL-2 mutein expands Tregs and prolongs transplant survival in preclinical models.

Efe O, Gassen R, Morena L, Ganchiku Y, Al Jurdi A, Lape I J Clin Invest. 2024; 134(5).

PMID: 38426492 PMC: 10904054. DOI: 10.1172/JCI173107.


A regulatory circuit controlled by extranuclear and nuclear retinoic acid receptor α determines T cell activation and function.

Larange A, Takazawa I, Kakugawa K, Thiault N, Ngoi S, Olive M Immunity. 2023; 56(9):2054-2069.e10.

PMID: 37597518 PMC: 10552917. DOI: 10.1016/j.immuni.2023.07.017.